These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

950 related articles for article (PubMed ID: 21184054)

  • 1. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
    Vasikaran S; Eastell R; Bruyère O; Foldes AJ; Garnero P; Griesmacher A; McClung M; Morris HA; Silverman S; Trenti T; Wahl DA; Cooper C; Kanis JA;
    Osteoporos Int; 2011 Feb; 22(2):391-420. PubMed ID: 21184054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.
    Vasikaran S; Cooper C; Eastell R; Griesmacher A; Morris HA; Trenti T; Kanis JA
    Clin Chem Lab Med; 2011 Aug; 49(8):1271-1274. PubMed ID: 21605012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.
    Szulc P; Naylor K; Hoyle NR; Eastell R; Leary ET;
    Osteoporos Int; 2017 Sep; 28(9):2541-2556. PubMed ID: 28631236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of biochemical markers in the management of osteoporosis.
    Henriksen K; Christiansen C; Karsdal MA
    Climacteric; 2015; 18 Suppl 2():10-8. PubMed ID: 26507704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability].
    Szulc P; Naylor K; Pickering ME; Hoyle N; Eastell R; Leary E
    Ann Biol Clin (Paris); 2018 Aug; 76(4):373-391. PubMed ID: 30078776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges.
    Bauer D; Krege J; Lane N; Leary E; Libanati C; Miller P; Myers G; Silverman S; Vesper HW; Lee D; Payette M; Randall S
    Osteoporos Int; 2012 Oct; 23(10):2425-33. PubMed ID: 22797491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study.
    Qu XL; Zheng B; Chen TY; Cao ZR; Qu B; Jiang T
    Orthop Surg; 2020 Feb; 12(1):116-123. PubMed ID: 31880071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.
    Yoshimura N; Muraki S; Oka H; Kawaguchi H; Nakamura K; Akune T
    Mod Rheumatol; 2011 Dec; 21(6):608-20. PubMed ID: 21512822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone turnover: Biology and assessment tools.
    Szulc P
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):725-738. PubMed ID: 30449551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of bone turnover markers in clinical practice.
    Biver E
    Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):468-73. PubMed ID: 23128576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of Bone Turnover Marker Measurement in the Treatment of Osteoporosis].
    Miura M; Satoh Y
    Yakugaku Zasshi; 2019; 139(1):27-33. PubMed ID: 30606924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of bone turnover markers for monitoring the treatment of osteoporosis in postmenopausal females undergoing total knee arthroplasty: a prospective randomized study.
    Ma R; Wu M; Li Y; Wang J; Yang P; Chen Y; Wang W; Song J; Wang K
    J Orthop Surg Res; 2021 Mar; 16(1):195. PubMed ID: 33731168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.
    Lorentzon M; Branco J; Brandi ML; Bruyère O; Chapurlat R; Cooper C; Cortet B; Diez-Perez A; Ferrari S; Gasparik A; Herrmann M; Jorgensen NR; Kanis J; Kaufman JM; Laslop A; Locquet M; Matijevic R; McCloskey E; Minisola S; Pikner R; Reginster JY; Rizzoli R; Szulc P; Vlaskovska M; Cavalier E
    Adv Ther; 2019 Oct; 36(10):2811-2824. PubMed ID: 31440982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone turnover markers are associated with higher cortical porosity, thinner cortices, and larger size of the proximal femur and non-vertebral fractures.
    Shigdel R; Osima M; Ahmed LA; Joakimsen RM; Eriksen EF; Zebaze R; Bjørnerem Å
    Bone; 2015 Dec; 81():1-6. PubMed ID: 26112819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of bone turnover marker concentrations in osteoporosis.
    Morris HA; Eastell R; Jorgensen NR; Cavalier E; Vasikaran S; Chubb SAP; Kanis JA; Cooper C; Makris K;
    Clin Chim Acta; 2017 Apr; 467():34-41. PubMed ID: 27374301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
    Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR
    J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Tamaki J; Iki M; Kadowaki E; Sato Y; Chiba Y; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
    Osteoporos Int; 2013 Mar; 24(3):887-97. PubMed ID: 22885773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Turnover Markers: Use in Fracture Prediction.
    Vilaca T; Gossiel F; Eastell R
    J Clin Densitom; 2017; 20(3):346-352. PubMed ID: 28716498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood.
    Bhattoa HP; Cavalier E; Eastell R; Heijboer AC; Jørgensen NR; Makris K; Ulmer CZ; Kanis JA; Cooper C; Silverman SL; Vasikaran SD;
    Clin Chim Acta; 2021 Apr; 515():16-20. PubMed ID: 33382995
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 48.